International Health Tech R&D Pilot Programme shortlist revealed
Shortlisted companies moving to stage 2 of our International Health Tech R&D Pilot Programme announced
7th March 2023
The NHSA is delighted to announce the 15 shortlisted companies that are moving to stage 2 of our International Health Tech R&D Pilot Programme.
The successful companies are (in alphabetical order):
- Cognishine Therapy and Education
- Cordio Medical
- Donisi health
- GistMD
- Ikko Health
- ImPlio
- Kemtai
- Nanovation
- Neurotrigger
- Pathkeeper
- Pulsenmore
- QLOG Technologies
- Sherman Diagnostics
- Visionsense
- Votis
The shortlisted companies will now work with NHSA members to develop their project plans to bring world leading R&D to the UK. They will receive support from the NHSA, the UK Israel Tech Hub and HealthIL to develop their ideas and deliver maximum impact for their business and UK patients.
The International Health Tech R&D pilot programme is led by the NHSA in the UK and the Israeli Innovation Authority in Israel to identify unmet clinical needs in the UK and identify potential solutions. We connect cutting edge health technologies to UK research and innovation expertise to stimulate transnational partnerships, accelerate the availability of medical innovations to the public, introduce Israeli healthcare technology to global markets, and advance the development of discoveries for the benefit of patients all over the world.
Related News Articles
Children in the North at greater risk of entering care
A new report has revealed the £25 billion children in care burden placed on stretched services in the North of England.
Read the articleWorld-renowned children’s hospital joins the Northern Health Science Alliance
Alder Hey Children’s NHS Foundation Trust has joined the Northern Health Science Alliance (NHSA) as the Trust continues to cement itself as a global leader in paediatric health and care.
Read the articleLiving in the North of England increases risk of death from alcohol, drugs and suicide
New study shows people living in the North of England are more likely to die from ‘death of despair’
Read the article